🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🌟 Jeffrey V. Lazarus has received the Eugene T. Davidson Public Service Award from AACE! This award recognises exceptional contributions to clinical excellence, education, research, public health, medical ethics and community engagement in the field of #endocrinology. 👏

I am truly honored to represent AACE as we endorse the Global Think-tank on Steatotic Liver Disease in Barcelona, Spain. I look forward to co-moderating a session with Holly Lofton on “The Power of Collaboration: Multidisciplinary Teams in the Early Diagnosis and Risk

🩺🌎 Who’s missing from the table in #LiverHealth decisions? Dr Naim Alkhouri reminds us why #Inclusion and #HealthEquity are essential for improving care in #SteatoticLiverDisease. 🔗 Read more: f.mtr.cool/shjodsukyz #SLDthinktank #PatientCentredCare cc Jeffrey V. Lazarus

🩺🌎 From patients to providers, real change in #LiverHealth starts with listening to those affected. A powerful reminder by Dr Naim Alkhouri via the #SLDThinkTank. 🔗 Read more: f.mtr.cool/lehbtoxkxx #SLDthinktank #HealthEquity #SLD #InMotionTogether #SteatoticLiverDisease

Scott Isaacs and Oliver Tavabie and myself enjoyed a great discussion reviewing all things MASLD and diabetes drugs in Frontline Gastro podcast on our paper fg.bmj.com/content/16/3/2… Have a listen here eur02.safelinks.protection.outlook.com/?url=https%3A%… EASLnews Jeffrey V. Lazarus University of Dundee BSG Trainees AACE

See you soon Scott and Paul at the Global Think-tank on Steatotic Liver Disease today in Barcelona. The hardworking nurses have been at a training since 9.00am!! Can't wait for your sessions. #SLDthinktank #LiverTwitter

What public health measures are effective in decreasing the burden of alcohol-related liver disease ? What new measures should be implemented ? We explain it all in this new article in Nature Reviews Gastroenterology & Hepatology

Metabolic dysfunction-associated steatohepatitis (MASH) drives rising morbidity and mortality, yet remains underdiagnosed. A new Health Policy paper by Jeffrey V. Lazarus and colleagues calls for community-based diagnostics: shorturl.at/a0COQ #LiverTwitter #SLDthinktank

We're at a critical point of needing to scale case-identification of those at risk of significant liver disease. Thanks to The Guardian for highlighting our study now available in the The Lancet Reg Health-Europe theguardian.com/society/2025/j… thelancet.com/journals/lanep… Jeffrey V. Lazarus Mazen Noureddin, MD, MHSc

Thanks to The Guardian for covering this important paper in this news : tinyurl.com/wuxj9uv6 "Millions in west do not know they have aggressive fatty liver disease, study says"

The Global Think-tank on Steatotic Liver Disease is proud to announce two groundbreaking publications: The People-First Liver Charter, in Nature Medicine nature.com/articles/s4159… 2. A call for doubling the MASH diagnostic rate: thelancet.com/journals/lanep… #SLDthinktank #LiverTwitter

And we are thrilled to see the coverage of steatotic liver disease today in the The Guardian! theguardian.com/society/2025/j… Naim Alkhouri Jörn Schattenberg Dídac Mauricio Luis Antonio Díaz, MD Scott Isaacs Paul Brennan #SLDthinktank #LiverTwitter

Using people-first language helps to reduce stigma, enhance care experiences, boost treatment engagement, and promote better health outcomes. The way we talk about diagnoses, causes, and lived experiences plays an important role in minimizing stigma and discrimination. Thank you

Yesterday, I joined a roundtable at the #GlobalThinkTank on Steatotic Liver Disease to discuss how cities can drive healthy lifestyles and prevent chronic diseases. Thanks to Jeffrey V. Lazarus and team for the kind invitation!

MASH with F2+ fibrosis is silently killing millions. This paper calls for DOUBLING diagnosis rates by 2027—using AI, NITs, and primary care. A paradigm shift is within reach. #MASLD #Hepatology #Publichealth Jeffrey V. Lazarus Paula Iruzubieta Sociedad Española de Patología Digestiva (SEPD) thelancet.com/journals/lanep…

We renamed a disease—not for science, but for people. 🩺 Proud to co-author the People-First Liver Charter alongside greats in Nature Portfolio 🔗 nature.com/articles/s4159… Words can heal. Let’s end stigma in MASLD/MASH—across every specialty. 🌍💬

ICYMI: I was honored to participate in EASL Education's recent online presentation, Steatotic Liver Disease Unpacked: Targeting Dynamic Risks. Watch here. #livertwitter Aleksander Krag Meena Bansal #EASLStudio #LiverXhttps://bit.ly/3FWSvI3